BModesto

Pharmaceutical Wholesale Distributionbmodesto.com

BModesto is a Dutch pharmaceutical wholesaler that parallel-imports, holds marketing authorizations for, and exclusively distributes medicines to pharmacies, outpatient pharmacies, and hospitals in the Netherlands, operating as part of Uniphar Group's Global Sourcing division.

Company typePrivate
Founded2014
HeadquartersLelystad, Netherlands
Headcount51–100
GTM typeB2B
OfferingServices

What BModesto does

BModesto B.V. is a Netherlands-based pharmaceutical wholesaler headquartered in Lelystad that specializes in the parallel importing, marketing, and distribution of medicines. Founded in 2014, the company operates as a subsidiary within the Global Sourcing division of Uniphar Group, an Irish-headquartered multinational pharmaceutical group. It serves three customer segments in the Dutch market: independent and chain pharmacies, outpatient (poliklinische) pharmacies, and hospitals, supplying them with parallel-imported and exclusively distributed pharmaceutical products at competitive prices.

The company's offering is structured around three interconnected service lines: parallel import (procuring identical medicines from EU member states where prices are lower and reselling them in the Netherlands), Merkhouder or Marketing Authorisation Holder services (holding marketing authorizations for various medicines to ensure availability), and exclusive distribution (marketing and distributing medicines on behalf of brand owners). Operations are built around regulatory compliance — BModesto holds GMP, GDP, and Wholesale Distribution Authorization (WDA) certifications, plus Green Deal sustainability compliance — and around a Dutch distribution network offering next-day delivery for orders placed before 16:00, with a €500 free-delivery threshold. Ordering is supported through multiple channels including electronic ordering via AIS, email, phone, live chat, and integrations with three Dutch pharmacy sorting systems: Smartfill, Odessa, and Speedfiller.

BModesto generates revenue through transaction-based parallel import and exclusive distribution, plus licensing/royalty-style income from its MAH holdings. Pricing is administered through monthly email price lists and publicly listed inventory positions, and the company emphasizes complementarity to incumbents — positioning itself as a supplemental assortment for pharmacies that already have a primary wholesaler relationship. The leadership team consists of founder and owner Michael Hendriks, and Robin Marcus, Director of Sales & Marketing. As a privately held Dutch B.V. without disclosed financials, BModesto is not a standalone investment-grade entity on its own, but rather a component of Uniphar's broader European pharmaceutical sourcing franchise.

BModesto firmographics

Firmographics

Name: BModesto
Legal name: BModesto B.V.
Website: https://bmodesto.com
Company type: Private
Founded year: 2014
Operating status: Operating
Headcount range: 51–100 employees
Short description: BModesto is a Dutch pharmaceutical wholesaler that parallel-imports, holds marketing authorizations for, and exclusively distributes medicines to pharmacies, outpatient pharmacies, and hospitals in the Netherlands, operating as part of Uniphar Group's Global Sourcing division.
Ownership category
akta.pro rank

BModesto industry classification

Industry

Product category: Pharmaceutical Wholesale Distribution
NAICS: Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC: Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro primary industry: Parallel Import/Export & Secondary Market Pharmaceutical Wholesalers (HLAIAJAK)
akta.pro secondary industry: Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA)

Keywords

Pharmaceutical wholesale
Parallel import medicines
Pharmaceutical distribution
Marketing authorization holder
Exclusive pharmaceutical distribution

Where BModesto is headquartered

Location

Headquarters

HQ city: Lelystad
HQ country: Netherlands
HQ region: Europe

Offices1 record

Markets served

BModesto business model

Business model

GTM type: B2B
Offering type: Services
Cost components: Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales

Revenue model

Parallel Import: Purchasing pharmaceutical products from EU countries where prices are lower and reselling them in the Netherlands at competitive rates to pharmacies, outpatient pharmacies, and hospitals.
Marketing Authorisation Holder (Merkhouder): Holding marketing authorizations for various medicines and ensuring optimal availability of these pharmaceutical products.
Exclusive Distribution: As exclusive distributor, marketing and distributing various medications to healthcare providers.

Pricing tiers

Model	Billing	Price
Transaction based/ take rate	Pay-as-you-go	Standard pharmaceutical pricing for pharmacies and hospitals

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

BModesto product offering

Product offering

Core offering

BModesto is an independent pharmaceutical wholesaler that parallel-imports medicines from EU countries where prices are lower, reselling them at competitive rates in the Netherlands. In addition, the company acts as a Marketing Authorization Holder (Merkhouder) for various medicines and serves as an exclusive distributor for brand owners, marketing and distributing medications to pharmacies, outpatient pharmacies, and hospitals.

Product overview

BModesto is an independent pharmaceutical wholesale company specializing in parallel import, brand holder activities, and exclusive distribution of medicines. The company operates three interconnected service lines: Parallel Import (procuring medicines from lower-tariff EU countries), Merkhouder (acting as marketing authorisation holder to ensure product availability), and Exclusieve Distributie (exclusive distribution and marketing of medicines). BModesto serves pharmacies, outpatient pharmacies, and hospitals across the Netherlands with a broad assortment of euro specialité and parallel-imported medicines, offering same-day delivery for orders placed before 16:00.

Differentiator

Problem solved

Functional benefit

Products and services

Parallel Import (Parallelle Import)
Merkhouder (Marketing Authorization Holder)
Exclusieve Distributie (Exclusive Distribution)

Companies that use BModesto

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

BModesto technology and API

Technology

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

BModesto partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

Uniphar Groupparent companyOthersBModesto is a subsidiary of Uniphar Group's Global Sourcing division. Uniphar is a multinational pharmaceutical group headquartered in Ireland that operates across Europe, providing international sourcing and distribution capabilities to BModesto.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

BModesto competitors and assessment

Company assessment

Direct peers

Alliance Healthcare Netherlands: Major Dutch pharmaceutical wholesaler serving pharmacies with broad assortment and distribution services; directly comparable as a parallel channel to Dutch pharmacies in the same regulatory and reimbursement framework as BModesto.
Trident Pharmaceuticals: European parallel-import pharmaceutical specialist supplying pharmacies across multiple EU markets; closest pure-play comparator to BModesto's parallel-import franchise.
Pluripharm: Dutch pharmaceutical wholesaler focused on independent pharmacies, offering parallel-imported medicines and full-line distribution — overlapping product mix, customer base, and channel with BModesto.

Broad incumbents

McKesson Europe / Lloyds Apotheek: Large European pharmaceutical wholesaler with pharmacy retail operations; serves as a broad incumbent competitor in the Dutch pharmacy supply chain alongside BModesto.
Phoenix Group (BENU Apotheek): Pan-European pharmaceutical wholesaler and pharmacy operator (BENU); competes with BModesto across the Dutch market while operating at vastly greater scale and breadth.
Mediq: Large Dutch healthcare distributor and wholesaler with pharmacy and direct-to-patient channels; broader portfolio than BModesto but directly comparable in pharmaceutical wholesale to Dutch providers.

Regional players

Tamro (Phoenix Group): Nordic pharmaceutical wholesaler operating under Phoenix, doing parallel import and full-line distribution; comparable business model to BModesto but operating in Northern Europe rather than the Netherlands.
Mawdsleys: UK-based pharmaceutical distributor specializing in parallel imports and special-order medicines; mirrors BModesto's parallel-import focus but serves the British market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

BModesto compliance and trust

Trust signal

Compliance4 records

BModesto financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BModesto leadership team

Management profile

Number of profiles

Profiles2 records

BModesto funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BModesto M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BModesto

What does BModesto do?

Is BModesto a public or private company?

BModesto is a private company. It is classified as corporate owned and is currently operating.

When was BModesto founded?

BModesto was founded in 2014. It employs 51 to 100 people.

Where is BModesto based?

BModesto is headquartered in Lelystad, Netherlands, in the Europe region.

How does BModesto make money?

Three revenue lines are on record. Parallel Import is the primary driver. The others are marketing Authorisation Holder (Merkhouder) and exclusive Distribution.

Who are BModesto's main competitors?

Direct peers on record are Alliance Healthcare Netherlands, Trident Pharmaceuticals and Pluripharm. Broad incumbents are McKesson Europe / Lloyds Apotheek, Phoenix Group (BENU Apotheek) and Mediq. Regional players are Tamro (Phoenix Group) and Mawdsleys.

Does BModesto have an API?

No public API is recorded for BModesto.

What industry is BModesto in?

BModesto's product category is Pharmaceutical Wholesale Distribution. Its primary akta.pro industry code is HLAIAJAK, Parallel Import/Export & Secondary Market Pharmaceutical Wholesalers, with a secondary code of CRAOAHAA, Prescription Pharmaceutical (Rx) Wholesale Distribution. Its NAICS code is 424210 and its SIC code is 5122.